By Ben Glickman
Shares of TradeUP Acquisition Corp. rose Friday after the company completed a business combination with Estrella Biopharma.
The stock was up 11% to $11.05 in midday trading. Shares have risen 7.1% this year.
The special-purpose acquisition company said Friday that it had completed a previously-announced merger with Estrella, a company developing therapies to treat blood cancers and solid tumors.
The combined company, which is now known as Estrella Immunopharma, will begin trading on the Nasdaq under the ticker ESLA starting Oct. 2.
TradeUP completed a private placement of shares with proceeds of $10 million directly before the merger closed, and Estrella closed its Series A preferred stock financings with proceeds of $9.75 million.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
September 29, 2023 12:25 ET (16:25 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。